TITLE

All-Cause Gastroenteritis and Rotavirus-Coded Hospitalizations Among US Children, 2000–2009

AUTHOR(S)
Desai, Rishi; Curns, Aaron T.; Steiner, Claudia A.; Tate, Jacqueline E.; Patel, Manish M.; Parashar, Umesh D.
PUB. DATE
August 2012
SOURCE
Clinical Infectious Diseases;8/15/2012, Vol. 55 Issue 4, pe28
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Since the approval of rotavirus vaccine in 2006 for routine use in US children, there has been a marked reduction in the number of and direct medical charges for all-cause gastroenteritis hospitalizations and rotavirus-coded hospitalizations.Background. Rotavirus vaccine was recommended for US infants in 2006. We estimated baseline prevaccine burden and monitored postvaccine trends in gastroenteritis-coded and rotavirus-coded hospitalizations among US children.Methods. We analyzed data from the State Inpatient Databases (SID) for 29–44 US states over a 10-year period (2000–2009) to calculate gastroenteritis and rotavirus-coded hospitalization rates by age group, sex, and region, among children <5 years of age. By extrapolating observed pre- and postvaccine gastroenteritis hospitalization rates to the US population <5 years and based on the 2009 cost of a diarrhea hospitalization, we estimated national reductions in diarrhea hospitalizations and associated treatment costs.Results. The prevaccine (2000–2006) annual average gastroenteritis-coded hospitalization rate among children <5 years of age was 74 per 10 000 (annual range, 71–82 per 10 000), and declined to 51 and 50 per 10 000 in 2008 and 2009, respectively (P < .001). The prevaccine (2000–2006) annual average rotavirus-coded hospitalization rate among children <5 years of age was 15 per 10 000 (annual range, 13–18 per 10 000), and declined to 5 and 6 per 10 000 in 2008 and 2009, respectively (P < .001). The decreases in rotavirus-coded hospitalization rates in 2008 and 2009 compared with rates in prevaccine years were observed among all age groups and US regions. Nationally, during 2008 and 2009 combined, we estimated a reduction of approximately 77 000 diarrhea hospitalizations and approximately $242 million in hospital costs.Conclusions. Since implementation of the US rotavirus vaccination program, a marked reduction in diarrhea hospitalizations and related hospital charges has occurred among US children.
ACCESSION #
78118607

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics